125 related articles for article (PubMed ID: 31740786)
1. BRF1 accelerates prostate tumourigenesis and perturbs immune infiltration.
Loveridge CJ; Slater S; Campbell KJ; Nam NA; Knight J; Ahmad I; Hedley A; Lilla S; Repiscak P; Patel R; Salji M; Fleming J; Mitchell L; Nixon C; Strathdee D; Neilson M; Ntala C; Bryson S; Zanivan S; Edwards J; Robson CN; Goodyear CS; Blyth K; Leung HY
Oncogene; 2020 Feb; 39(8):1797-1806. PubMed ID: 31740786
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of the TFIIIB subunits Brf1 and Brf2 in cancer cells.
Cabarcas S; Jacob J; Veras I; Schramm L
BMC Mol Biol; 2008 Aug; 9():74. PubMed ID: 18700021
[TBL] [Abstract][Full Text] [Related]
3. IMP3 accelerates the progression of prostate cancer through inhibiting PTEN expression in a SMURF1-dependent way.
Zhang X; Wang D; Liu B; Jin X; Wang X; Pan J; Tu W; Shao Y
J Exp Clin Cancer Res; 2020 Sep; 39(1):190. PubMed ID: 32938489
[TBL] [Abstract][Full Text] [Related]
4. The transcription factor Sp1 modulates RNA polymerase III gene transcription by controlling
Peng F; Zhou Y; Wang J; Guo B; Wei Y; Deng H; Wu Z; Zhang C; Shi K; Li Y; Wang X; Shore P; Zhao S; Deng W
J Biol Chem; 2020 Apr; 295(14):4617-4630. PubMed ID: 32115405
[TBL] [Abstract][Full Text] [Related]
5. Increased T-cell Infiltration Elicited by
Loveridge CJ; Mui EJ; Patel R; Tan EH; Ahmad I; Welsh M; Galbraith J; Hedley A; Nixon C; Blyth K; Sansom O; Leung HY
Cancer Res; 2017 Jun; 77(12):3158-3168. PubMed ID: 28515147
[TBL] [Abstract][Full Text] [Related]
6. The significance of Runx2 mediating alcohol-induced Brf1 expression and RNA Pol III gene transcription.
Hong Z; Fang Z; Lei J; Shi G; Zhang Y; He Z; Li B W; Zhong S
Chem Biol Interact; 2020 May; 323():109057. PubMed ID: 32198086
[TBL] [Abstract][Full Text] [Related]
7. Role of Brf1 interaction with ERα, and significance of its overexpression, in human breast cancer.
Fang Z; Yi Y; Shi G; Li S; Chen S; Lin Y; Li Z; He Z; Li W; Zhong S
Mol Oncol; 2017 Dec; 11(12):1752-1767. PubMed ID: 28972307
[TBL] [Abstract][Full Text] [Related]
8. Paucity of PD-L1 expression in prostate cancer: innate and adaptive immune resistance.
Martin AM; Nirschl TR; Nirschl CJ; Francica BJ; Kochel CM; van Bokhoven A; Meeker AK; Lucia MS; Anders RA; DeMarzo AM; Drake CG
Prostate Cancer Prostatic Dis; 2015 Dec; 18(4):325-32. PubMed ID: 26260996
[TBL] [Abstract][Full Text] [Related]
9. TFIIB-related factor 1 is a nucleolar protein that promotes RNA polymerase I-directed transcription and tumour cell growth.
Wang J; Chen Q; Wang X; Zhao S; Deng H; Guo B; Zhang C; Song X; Deng W; Zhang T; Ni H
Hum Mol Genet; 2023 Jan; 32(1):104-121. PubMed ID: 35925837
[TBL] [Abstract][Full Text] [Related]
10. Prostate-specific G-protein-coupled receptor collaborates with loss of PTEN to promote prostate cancer progression.
Rodriguez M; Siwko S; Zeng L; Li J; Yi Z; Liu M
Oncogene; 2016 Mar; 35(9):1153-62. PubMed ID: 26028029
[TBL] [Abstract][Full Text] [Related]
11. The significance of Brf1 overexpression in human hepatocellular carcinoma.
Zhong Q; Xi S; Liang J; Shi G; Huang Y; Zhang Y; Levy D; Zhong S
Oncotarget; 2016 Feb; 7(5):6243-54. PubMed ID: 26701855
[TBL] [Abstract][Full Text] [Related]
12. RNF12 catalyzes BRF1 ubiquitination and regulates RNA polymerase III-dependent transcription.
Wang F; Zhao K; Yu S; Xu A; Han W; Mei Y
J Biol Chem; 2019 Jan; 294(1):130-141. PubMed ID: 30413534
[TBL] [Abstract][Full Text] [Related]
13. Differential role of PTEN in transforming growth factor β (TGF-β) effects on proliferation and migration in prostate cancer cells.
Kimbrough-Allah MN; Millena AC; Khan SA
Prostate; 2018 Apr; 78(5):377-389. PubMed ID: 29341212
[TBL] [Abstract][Full Text] [Related]
14. Loss of PTEN permits CXCR4-mediated tumorigenesis through ERK1/2 in prostate cancer cells.
Chetram MA; Odero-Marah V; Hinton CV
Mol Cancer Res; 2011 Jan; 9(1):90-102. PubMed ID: 21076047
[TBL] [Abstract][Full Text] [Related]
15. RUNX2 overexpression and PTEN haploinsufficiency cooperate to promote CXCR7 expression and cellular trafficking, AKT hyperactivation and prostate tumorigenesis.
Bai Y; Yang Y; Yan Y; Zhong J; Blee AM; Pan Y; Ma T; Karnes RJ; Jimenez R; Xu W; Huang H
Theranostics; 2019; 9(12):3459-3475. PubMed ID: 31281490
[No Abstract] [Full Text] [Related]
16. p300 acetyltransferase regulates androgen receptor degradation and PTEN-deficient prostate tumorigenesis.
Zhong J; Ding L; Bohrer LR; Pan Y; Liu P; Zhang J; Sebo TJ; Karnes RJ; Tindall DJ; van Deursen J; Huang H
Cancer Res; 2014 Mar; 74(6):1870-1880. PubMed ID: 24480624
[TBL] [Abstract][Full Text] [Related]
17. Exploring the Role and Mechanism of pAMPK
Wu T; Zhang D; Lin M; Yu L; Dai T; Li S; Yu F; Lu L; Zheng L; Zhong S
Oxid Med Cell Longev; 2021; 2021():5554932. PubMed ID: 33995823
[TBL] [Abstract][Full Text] [Related]
18. Proteomic and transcriptomic profiling of Pten gene-knockout mouse model of prostate cancer.
Zhang J; Kim S; Li L; Kemp CJ; Jiang C; Lü J
Prostate; 2020 May; 80(7):588-605. PubMed ID: 32162714
[TBL] [Abstract][Full Text] [Related]
19. CD4
Liu S; Liu F; Zhang B; Yan P; Rowan BG; Abdel-Mageed AB; Steele C; Jazwinski SM; Moroz K; Norton EB; Wang A; Myers L; Sartor O; Zhang Q
Prostate; 2020 Jul; 80(10):764-776. PubMed ID: 32356608
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor-type 1 receptor inhibitor NVP-AEW541 enhances radiosensitivity of PTEN wild-type but not PTEN-deficient human prostate cancer cells.
Isebaert SF; Swinnen JV; McBride WH; Haustermans KM
Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):239-47. PubMed ID: 21816290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
